Product custom-nanocomposites-lipid-nanoparticle-composite-materials

Home > products > custom-nanocomposites> lipid-nanoparticle-composite-materials

Catalog	name	Description	price
R-Mcs-558	RGD-PEG-CMC-SH@Gambogic acid NPs	RGD-PEG-CMC-SH@Gambogic acid NPs/RGD-PEG-Carboxymethyl cellulose-SH@Gambogic Acid nanoparticles are a multifunctional nano delivery system that integrates active targeting, efficient drug loading, and low toxicity characteristics. The product can significantly enhance the water solubility and in vivo stability of ferulic acid, and enhance drug enrichment in tumor sites through the dual effects of EPR effect and active targeting. While reducing the systemic toxicity of ferulic acid, it fully utilizes its activity in inducing tumor cell apoptosis and inhibiting angiogenesis, providing efficient tools for precise tumor treatment and related biomedical research.	price>
R-Mcs-562	NH2-PEG2k-RVG29 modified black phosphorus nanosheets@metformin hydrochloride,±100nm	NH2-PEG2k-RVG29 modified black phosphorus nanosheets @metformin hydrochloride,±100nm is an intelligent nano delivery system for the treatment of brain diseases. It combines the photothermal properties of black phosphorus, enhanced PEGylation stability, and the neural targeting ability of RVG29 peptide segment to achieve precise drug delivery in the central nervous system.	price>
R-Mcs-571	Liposomal nanoparticles@zoledronic acid surface modified with mannose,±100nm	Liposomal nanoparticles@zoledronic acid surface modified with mannose,±100nm/Liposomal nanoparticles loaded with zoledronic acid surface modified with mannose is a multifunctional liposome nanoparticle carrier that combines bone targeting and immunomodulatory potential.	price>
R-Mcs-572	FA@MoSe2@TA-Cu(copper tannate)	FA@MoSe2@TA-Cu(copper tannate)/FA-MoSe2@TA-Cu(copper tannate)/FA modified MoSe2 nanoflowers loaded with copper tannate (TA-Cu)/Folic acid modifiedMolybdenumselenide(MoSe2) nanoflowers loaded with copper tannate is a composite nano functional material. This material is generally used in tumor synergistic therapy research, combining multiple advantages of targeting ability, catalytic therapy, and copper death therapy.	price>
R-Mcs-578	HSA-Ca3(PO4)2@FePt nanoparticles	HSA-Ca3(PO4)2@FePt nanoparticles/Human serum albumin-calcium phosphate coated FePt nanoparticles/HSA-calcium phosphate coated FePt nanoparticles are composite nanoparticles that belong to the functional nanomaterials of multimodal diagnosis and treatment integration, and are commonly used in the diagnosis and treatment research of tumors.	price>
R-GHLS-100NM	Calcein Liposome （100nm）	Calcein Liposome from ruixi.Compared with the aqueous solution of calcein, the liposome can greatly increase the amount of calcein in the passive transmembrane, which is mainly distributed in lysosomes. The small molecule water-soluble drugs can change the way of entering cells, improve the ability of entering cells and affect the intracellular distribution.	price>
R-R-5665	HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes	HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes. PEGylated liposomes containing free maleimide functional group for maleimide-thiol conjugation. The liposomes are co-formulated with 1 mol% DSPE-mPEG2000-maleimide, and supplied in a pH-optimized buffer for direct conjugation of the thiol-containing molecule of choice. Conjugation can be achieved by incubating the liposomes with the activated thiol-containing compound which has been reduced by a disulfide bond reducing agent such as (tris(2-carboxyethyl)phosphine) (TCEP), which can be purchased as an add-on.	price>
R-R-5666	Tanespimycin (17-AAG) Liposomes, Formulation XT28.1	Tanespimycin (17-AAG) Liposomes, Formulation XT28.1. PEGylated liposomes containing Hsp90 inhibitor Tanespimycin (17-AAG). Tanespimycin exhibits 100-fold higher binding affinity to HSP90 derived from tumor cells vs normal cells, and induces apoptosis, necrosis, autophagy, and mitophagy. Tanespimycin is insoluble in aqueous media. This product is a pre-formulated liposomal version of Tanespimycin which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.	price>
R-R-5667	DT-061 (SMAP) Liposomes, Formulation TT-40	DT-061 (SMAP) Liposomes, Formulation TT-40. PEGylated liposomes containing PP2A activator DT-061 (SMAP). DT-061 is an activator of protein phosphatase 2A (PP2A). PP2A regulates many cellular signaling pathways including MAPK/ERK, Wnt/β-catenin, Akt/mTOR, GSK3β, p53/apoptosis, cell cycle, and others. This product can be used in vitro or in vivo for studying the effects of PP2A activation and could be applied to preclinical therapy of KRAS-mutant and MYC-driven tumors. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.	price>
R-R-5668	Liposomes for Loading Hydrophobic Drugs	Liposomes for Loading Hydrophobic Drugs (5.0mL). This pre-formed liposome product is created for post loading of hydrophobic small molecule compounds into liposomes. The process of drug incorporation is very straight-forward. Then simply add an aliquot of drug solution (prepared in a water-miscible solvent such as ethanol, DMSO and etc.) into the liposome suspension. The drug molecules can be incorporated into the lipid bilayers by the nature of hydrophobic interactions. The drug solubility therefore could be significantly enhanced. Liposomal drug concentration of 1-2 mg/mL could be achieved for most lipophilic drugs. PEGylation of the liposomes provides not only better formulation stability but also the potential of achieving prolonged in vivo blood circulation. The finished drug loaded formulations are suitable for either in vitro testing or in vivo studies.	price>

...